Private Equity Firm Plans $1.5 Billion Drug-Deal Fund

LONDON, Dec 11 (Reuters) - A private equity group specialising in buying and selling pharmaceutical products aims to raise some $1.5 billion for two funds to exploit the growing demand from "Big Pharma" for biotech drugs, it said on Tuesday.